GW Pharmaceuticals Release: Preliminary Results for the Year Ended 30 September 2007

January 23, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Porton Down, UK, 22 January 2008: GW Pharmaceuticals plc (AIM: GWP), the developer and manufacturer of a range of new cannabinoid medicines including Sativex®, announces its preliminary results for the year ended 30 September 2007.

Twitter
LinkedIn
Facebook
Email
Print

Earnings Europe